Psioxus Therapeutics

PsiOxus aims to be the world’s leading cancer gene therapy company, delivering medicines of value to patients with cancer. They focus on discovering and developing innovative gene-based immuno-oncology treatments for solid tumors using their proprietary intravenously administered T-SIGn virus platform. Their portfolio of differentiated gene therapy products are all delivered systemically but act locally within the tumor. At PsiOxus they are advancing their internal early and clinical stage candidates and establishing strategic partnerships with immuno-oncology leaders to bring their cancer gene therapy products to patients. They focus on discovering and developing innovative gene-based immuno-oncology treatments for solid tumors using their proprietary intravenously administered T-SIGn virus platform. Their portfolio of differentiated gene therapy products are all delivered systemically but act locally within the tumor.

show less